Reuters - A new attention deficit drug made by Shire Plc and New River Pharmaceuticals Inc. is "approvable" by U.S. regulators for children ages 6 to 12 pending a decision by drug enforcement authorities on the level of control it will be subject to, the ...

Blog Registration & Privacy October 3rd, 2006 I have had some feedback that some of you might be concerned about registering to make comments on this...

Biomedical Science and Engineering Series...